查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951909

次世代定序資料分析市場分析及預測（至2035年）：按類型、產品、服務、技術、組件、應用、最終用戶和解決方案分類

Next generation Sequencing Data Analysis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Solutions
出版日期: | 出版商: Global Insight Services | 英文 349 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

次世代定序資料分析市場預計將從2024年的8.129億美元成長到2034年的64.1億美元，複合年成長率約為24.5%。次世代定序數據的解決方案和服務，這對於個人化醫療和生物技術至關重要。這些解決方案和服務包括生物資訊學工具、雲端運算和人工智慧驅動的分析，有助於快速且準確地洞察基因變異。市場成長的驅動力主要來自於定序技術的進步及其在臨床診斷和研究領域不斷擴展的應用。

次世代定序資料分析市場預計將穩定成長，這主要得益於基因組研究和個人化醫療的進步。軟體領域主導，生物資訊工具和資料解讀平台在其中發揮關鍵作用，它們在將原始資料轉化為可操作的洞見方面發揮著重要作用。在該領域中，變異檢測工具和基因組註釋工具表現尤為出色，它們對於識別基因變異和功能元件至關重要。服務領域緊隨其後，這主要得益於數據分析外包給專業服務提供者的趨勢日益成長。在服務領域，資料管理和儲存解決方案的重要性日益凸顯，以滿足對高效處理海量基因組資料集的日益成長的需求。儘管雲端平台因其擴充性和成本效益而越來越受歡迎，但對於優先考慮資料安全的機構而言，本地部署解決方案仍然至關重要。此外，科技公司與研究機構之間的合作正在推動市場發展，促進創新並提升分析能力。人工智慧 (AI) 和機器學習的融合有望透過最佳化數據處理和預測分析來推動未來的成長。

市場區隔
類型 全基因組定序、EXOME定序、標靶定序、RNA定序、表觀基因學、宏總體基因體學、從頭定序、單細胞定序
產品 軟體、平台、試劑盒和試劑、耗材
服務 數據分析、數據管理、數據解讀與諮詢服務
科技 合成定定序、離子半導體定序、焦磷酸測序、單分子即時定序、奈米孔定序
成分 硬體、軟體和服務
目的 臨床診斷、藥物研發、農業與動物研究、生物標記發現、法醫學
最終用戶 學術研究機構、製藥和生物技術公司、醫院和診所、診斷檢查室
解決方案 本機部署、雲端部署、混合式部署

次世代定序資料分析市場持續穩定成長，提供創新解決方案的公司佔據了顯著的市場佔有率。定價策略競爭激烈，反映出市場對先進定序技術的需求日益成長。頻繁的新產品發布凸顯了該市場的活力。各公司正致力於提高數據的準確性和速度，這對於保持競爭優勢至關重要。雲端解決方案的採用尤其值得關注，因為它們提供了擴充性和柔軟性。北美繼續保持主導地位，而亞太地區則在技術進步和日益活躍的研究活動的推動下，展現出令人矚目的投資趨勢。次世代定序資料分析市場的競爭異常激烈，主要參與者不斷評估競爭對手的狀況。監管的影響在北美和歐洲尤為顯著，嚴格的指導方針影響市場動態。遵守這些法規對於市場准入和永續性至關重要。各公司正利用策略聯盟和收購來鞏固其市場地位。這個市場的特點是技術快速發展，這既帶來了機遇，也帶來了挑戰。雖然人工智慧 (AI) 和機器學習的整合有望推動創新，但監管障礙和資料隱私問題仍然是重大挑戰。

主要趨勢和促進因素：

次世代定序(NGS) 資料分析市場正經歷強勁成長，這主要得益於技術進步和定序方案的日益普及，這些解決方案能夠實現擴充性、柔軟性且協作式的數據分析。對於尋求有效管理海量資料集的研究機構和生物技術公司而言，這些解決方案尤其具有吸引力。此外，個人化醫療的興起也推動了對 NGS 數據分析的需求，因為它能夠基於個別基因譜制定治療方案。監管支持和政府資助也是關鍵促進因素，它們促進了基因組研究和開發。這些努力促進了創新並拓展了市場機會。此外，慢性病盛行率的不斷上升也需要更先進的基因組研究，進一步加速了市場成長。能夠提供全面且易於使用的分析平台的公司將佔據有利地位，從而掌握這一蓬勃發展的機會。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 全基因組定序
    • EXOME定序
    • 標靶定序
    • RNA定序
    • 表觀基因
    • 總體基因體學
    • 從頭測序
    • 單細胞定序
  • 市場規模及預測：依產品分類
    • 軟體
    • 平台
    • 試劑盒和試劑
    • 消耗品
  • 市場規模及預測：依服務分類
    • 數據分析
    • 資料管理
    • 數據解讀
    • 諮詢服務
  • 市場規模及預測：依技術分類
    • 合成定定序
    • 離子半導體定序
    • 焦磷酸測序
    • 單分子即時定序
    • 奈米孔定序
  • 市場規模及預測：依組件分類
    • 硬體
    • 軟體
    • 服務
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 藥物發現
    • 農業/動物研究
    • 生物標記發現
    • 法醫學
  • 市場規模及預測：依最終用戶分類
    • 學術研究機構
    • 製藥和生物技術公司
    • 醫院和診所
    • 診斷檢查室
  • 市場規模及預測：按解決方案分類
    • 本地部署
    • 基於雲端的
    • 混合

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • BGI Genomics
  • Roche Sequencing Solutions
  • Genomatix
  • DNASTAR
  • Partek Incorporated
  • Seven Bridges Genomics
  • Genalice
  • Golden Helix
  • Biomatters
  • Geno Logics
  • CLC bio
  • DNAnexus
  • Congenica
  • Fabric Genomics

第9章：關於我們

簡介目錄
Product Code: GIS21359

Next generation Sequencing Data Analysis Market is anticipated to expand from $812.9 million in 2024 to $6,410.0 million by 2034, growing at a CAGR of approximately 24.5%. The Next Generation Sequencing Data Analysis Market encompasses solutions and services for interpreting complex genomic data, pivotal for personalized medicine and biotechnology. It involves bioinformatics tools, cloud computing, and AI-driven analytics, facilitating rapid and accurate insights into genetic variations. The market's growth is propelled by advancements in sequencing technologies and increasing applications in clinical diagnostics and research.

The Next Generation Sequencing Data Analysis Market is poised for robust expansion, driven by advancements in genomic research and personalized medicine. The software segment dominates, with bioinformatics tools and data interpretation platforms leading due to their critical role in translating raw data into actionable insights. Within this segment, variant calling and genome annotation tools are top performers, essential for identifying genetic variations and functional elements. The services segment follows, propelled by the increasing outsourcing of data analysis to specialized providers. Within services, data management and storage solutions are gaining prominence, addressing the growing need for efficient handling of vast genomic datasets. Cloud-based platforms are becoming increasingly popular, offering scalability and cost-effectiveness, while on-premise solutions continue to be significant for institutions prioritizing data security. The market is further bolstered by collaborations between technology companies and research institutions, fostering innovation and enhancing analytical capabilities. The integration of artificial intelligence and machine learning is expected to drive future growth, optimizing data processing and predictive analytics.

Market Segmentation
TypeWhole Genome Sequencing, Exome Sequencing, Targeted Sequencing, RNA Sequencing, Epigenomics, Metagenomics, De Novo Sequencing, Single-cell Sequencing
ProductSoftware, Platforms, Kits and Reagents, Consumables
ServicesData Analysis, Data Management, Data Interpretation, Consulting Services
TechnologySequencing by Synthesis, Ion Semiconductor Sequencing, Pyrosequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing
ComponentHardware, Software, Services
ApplicationClinical Diagnosis, Drug Discovery, Agricultural and Animal Research, Biomarker Discovery, Forensic Science
End UserAcademic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories
SolutionsOn-premise, Cloud-based, Hybrid

The Next Generation Sequencing Data Analysis Market is experiencing robust growth, with significant market share held by companies offering innovative solutions. Pricing strategies are competitive, reflecting the increasing demand for advanced sequencing technologies. New product launches are frequent, underscoring the dynamic nature of this market. Companies are focusing on enhancing data accuracy and speed, which is crucial for maintaining a competitive edge. The adoption of cloud-based solutions is particularly noteworthy, as it offers scalability and flexibility. North America remains a leader, while the Asia-Pacific region shows promising investment trends, driven by technological advancements and increased research activities. Competition in the Next Generation Sequencing Data Analysis Market is intense, with key players continuously benchmarking their offerings against competitors. Regulatory influences are significant, particularly in North America and Europe, where stringent guidelines impact market dynamics. Compliance with these regulations is essential for market entry and sustainability. Companies are leveraging strategic partnerships and acquisitions to strengthen their market positions. The market is characterized by rapid technological advancements, which present both opportunities and challenges. The integration of artificial intelligence and machine learning is expected to drive innovation, while regulatory hurdles and data privacy concerns remain critical issues to address.

Geographical Overview:

The Next Generation Sequencing (NGS) Data Analysis Market is witnessing robust growth across multiple regions, each exhibiting unique characteristics. North America leads the market, propelled by advanced healthcare infrastructure and significant investments in genomic research. The region's strong focus on precision medicine and personalized healthcare further accelerates market expansion. Europe follows, with substantial government funding and a well-established research ecosystem driving NGS adoption. The region's stringent regulatory frameworks ensure data quality and security, enhancing market credibility. In the Asia Pacific, rapid technological advancements and increasing healthcare expenditure are key growth drivers. Countries like China and India are emerging as significant players, investing heavily in genomic research and bioinformatics. Latin America and the Middle East & Africa present burgeoning opportunities. In Latin America, rising awareness of genomics and improved healthcare access are catalysts for growth. The Middle East & Africa are investing in healthcare modernization, recognizing NGS's potential in advancing medical research and diagnostics.

The Next Generation Sequencing Data Analysis Market is profoundly influenced by global tariff policies, geopolitical dynamics, and evolving supply chain strategies. In Japan and South Korea, heightened trade tensions with the US are prompting a strategic pivot toward domestic innovation in sequencing technologies to mitigate tariff-induced costs. China's focus on self-reliance is accelerating its investment in indigenous sequencing solutions amidst export restrictions. Taiwan, while a pivotal player in semiconductor manufacturing, faces geopolitical vulnerabilities that could impact its market stability. Globally, the parent market shows robust growth, driven by advancements in personalized medicine and genomics. By 2035, market evolution will hinge on resilient supply chains and strategic partnerships. Meanwhile, Middle East conflicts pose risks to energy prices, potentially affecting operational costs and timelines across the sector.

Key Trends and Drivers:

The Next Generation Sequencing (NGS) Data Analysis Market is experiencing robust growth, driven by technological advancements and decreasing sequencing costs. A key trend is the integration of artificial intelligence and machine learning, which is enhancing data interpretation accuracy and efficiency. This integration is enabling researchers to derive more meaningful insights from complex genomic data. Another significant trend is the increasing adoption of cloud-based solutions, which facilitate scalable, flexible, and collaborative data analysis. These solutions are particularly appealing to research institutions and biotech companies looking to manage vast datasets effectively. Furthermore, the rise of personalized medicine is propelling demand for NGS data analysis, as it allows for tailored therapeutic approaches based on individual genetic profiles. Regulatory support and government funding are also pivotal drivers, encouraging research and development in genomics. These initiatives are fostering innovation and expanding market opportunities. Additionally, the growing prevalence of chronic diseases is necessitating advanced genomic research, further fueling market growth. Companies that can offer comprehensive, user-friendly analysis platforms are poised to capitalize on these burgeoning opportunities.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Whole Genome Sequencing
    • 4.1.2 Exome Sequencing
    • 4.1.3 Targeted Sequencing
    • 4.1.4 RNA Sequencing
    • 4.1.5 Epigenomics
    • 4.1.6 Metagenomics
    • 4.1.7 De Novo Sequencing
    • 4.1.8 Single-cell Sequencing
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Software
    • 4.2.2 Platforms
    • 4.2.3 Kits and Reagents
    • 4.2.4 Consumables
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Data Analysis
    • 4.3.2 Data Management
    • 4.3.3 Data Interpretation
    • 4.3.4 Consulting Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Sequencing by Synthesis
    • 4.4.2 Ion Semiconductor Sequencing
    • 4.4.3 Pyrosequencing
    • 4.4.4 Single-molecule Real-time Sequencing
    • 4.4.5 Nanopore Sequencing
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnosis
    • 4.6.2 Drug Discovery
    • 4.6.3 Agricultural and Animal Research
    • 4.6.4 Biomarker Discovery
    • 4.6.5 Forensic Science
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Academic and Research Institutes
    • 4.7.2 Pharmaceutical and Biotechnology Companies
    • 4.7.3 Hospitals and Clinics
    • 4.7.4 Diagnostic Laboratories
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 On-premise
    • 4.8.2 Cloud-based
    • 4.8.3 Hybrid

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Qiagen
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Thermo Fisher Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Agilent Technologies
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Oxford Nanopore Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Pacific Biosciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 BGI Genomics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Roche Sequencing Solutions
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Genomatix
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 DNASTAR
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Partek Incorporated
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Seven Bridges Genomics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Genalice
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Golden Helix
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Biomatters
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Geno Logics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 CLC bio
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 DNAnexus
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Congenica
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Fabric Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us